These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 3794379)

  • 1. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
    Stief CG; Bähren W; Beckert R; Altwein JE
    J Urol (Paris); 1986; 92(6):349-51. PubMed ID: 3794379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Corpus cavernosum injection treatment of erectile impotence].
    Lenk S; Schönherr G; Korner I
    Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM; Gaston R; Piechaud T; Le Guillou M
    Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction].
    Steffens J; Postma HJ; Steffens L
    Urologe A; 1988 Jan; 27(1):14-6. PubMed ID: 3363768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3 years' experience with intracavernous auto-injection therapy].
    Weiske WH
    Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term results of corpus cavernosum auto-injection therapy in treatment of patients with chronic erectile dysfunction].
    Gall H; Sparwasser C; Bähren W; Scherb W; Holzki G; Irion R
    Urologe A; 1992 Jan; 31(1):31-6. PubMed ID: 1553802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
    Stief CG; Gilbert P; Wetterhauer U; Bähren W; Thon W; Altwein JE
    Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
    Thon WF; Hartmann U
    Urologe A; 1993 Nov; 32(6):466-9. PubMed ID: 8284856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracavernous pharmacotherapy for organic impotence in the elderly].
    Richter S; Shalev M; Nissenkorn I
    Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of an erection using papaverine].
    Terek A; Sekei J; Getz F
    Urol Nefrol (Mosk); 1989; (3):69-71. PubMed ID: 2773185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intracavernous pharmacotherapy.
    Sidi AA
    Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracavernous self-injection for treatment of erectile dysfunction inpatients with spinal cord injuries].
    Sønksen JO; Hansen EF; Biering-Sørensen F; Colstrup H
    Ugeskr Laeger; 1990 Oct; 152(41):3006-9. PubMed ID: 2238171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracavernosal injection therapy for impotence: preliminary results.
    Gilling PJ; Wright WL; Gray JM
    N Z Med J; 1988 Jun; 101(848):423-4. PubMed ID: 3393333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.